|
|
|
|
|
|
|
Rebecca J. Anderson, Ph.D. R & D Budgets and Planning, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut |
|
|
|
|
|
|
|
|
Umesh V. Banakar, Ph.D. Professor of Pharmaceutics and Director of Research, St. Louis College of Pharmacy, St. Louis, Missouri |
|
|
|
|
|
|
|
|
Bret Berner, Ph.D. Executive Director of Development, Cygnus, Inc., Redwood City, California |
|
|
|
|
|
|
|
|
Alan Bye, Ph.D. International Director, Glaxo-Wellcome Inc., Research Triangle Park, North Carolina |
|
|
|
|
|
|
|
|
D. Bruce Campbell, Ph.D. Director of International Scientific Affairs, Servier Research and Development Ltd., Fulmer, Slough, England |
|
|
|
|
|
|
|
|
Jim Cassidy, M.D., Ph.D. Professor of Oncology, University of Aberdeen, Aberdeen, Scotland |
|
|
|
|
|
|
|
|
W.J.C. Currie, M.D. Executive Director, Clinical and Regulatory Development, Merck & Co., Inc., Rahway, New Jersey |
|
|
|
|
|
|
|
|
Dai Davies, Ph.D. Clinical Pathology Laboratory, Zeneca Pharmaceuticals, Cheshire, England |
|
|
|
|
|
|
|
|
Jan Gugliotti, M.B.A. CSC Index, Cambridge, Massachusetts |
|
|
|
|
|